These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17182591)

  • 61. Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome.
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Van Raemdonck DE; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2009 Aug; 28(8):799-807. PubMed ID: 19632576
    [TBL] [Abstract][Full Text] [Related]  

  • 62. On interleukin-8, neutrophil activation, and bronchiolitis obliterans syndrome in lung transplantation.
    Riise GC
    Transplantation; 2000 Jul; 70(2):265-6. PubMed ID: 10933146
    [No Abstract]   [Full Text] [Related]  

  • 63. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.
    Hertz MI; Henke CA; Nakhleh RE; Harmon KR; Marinelli WA; Fox JM; Kubo SH; Shumway SJ; Bolman RM; Bitterman PB
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10385-9. PubMed ID: 1438225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
    Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I
    Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Zisman DA; Xue YY; Li K; Ardehali A; Ross DJ; Strieter RM
    J Immunol; 2003 Nov; 171(9):4844-52. PubMed ID: 14568964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
    Krenn K; Gmeiner M; Paulus P; Sela N; Torres L; Zins K; Dekan G; Aharinejad S
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1194-202. PubMed ID: 25595376
    [TBL] [Abstract][Full Text] [Related]  

  • 67. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.
    Medoff BD; Seung E; Wain JC; Means TK; Campanella GS; Islam SA; Thomas SY; Ginns LC; Grabie N; Lichtman AH; Tager AM; Luster AD
    J Exp Med; 2005 Jul; 202(1):97-110. PubMed ID: 15998790
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans.
    Boehler A; Chamberlain D; Xing Z; Slutsky AS; Jordana M; Gauldie J; Liu M; Keshavjee S
    Hum Gene Ther; 1998 Mar; 9(4):541-51. PubMed ID: 9525315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.
    Gupta PK; Wagner SR; Wu Q; Shilling RA
    Am J Respir Cell Mol Biol; 2017 Jun; 56(6):708-715. PubMed ID: 28118023
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immune cells in a mouse airway model of obliterative bronchiolitis.
    Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.
    Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI
    Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802
    [TBL] [Abstract][Full Text] [Related]  

  • 74. B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease.
    Xu Z; Ramachandran S; Gunasekaran M; Nayak D; Benshoff N; Hachem R; Gelman A; Mohanakumar T
    Am J Transplant; 2016 Apr; 16(4):1173-82. PubMed ID: 26844425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic polymorphisms and bronchiolitis obliterans syndrome after lung transplantation: promising results and recommendations for the future.
    Kastelijn EA; van Moorsel CH; Ruven HJ; Lammers JW; Grutters JC
    Transplantation; 2012 Jan; 93(2):127-35. PubMed ID: 22138817
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.
    DiGiovine B; Lynch JP; Martinez FJ; Flint A; Whyte RI; Iannettoni MD; Arenberg DA; Burdick MD; Glass MC; Wilke CA; Morris SB; Kunkel SL; Strieter RM
    J Immunol; 1996 Nov; 157(9):4194-202. PubMed ID: 8892657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome.
    Reznik SI; Jaramillo A; Zhang L; Patterson GA; Cooper JD; Mohanakumar T
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):39-45. PubMed ID: 10612759
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.
    Gregson AL; Hoji A; Palchevskiy V; Hu S; Weigt SS; Liao E; Derhovanessian A; Saggar R; Song S; Elashoff R; Yang OO; Belperio JA
    PLoS One; 2010 Jun; 5(6):e11354. PubMed ID: 20613873
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome.
    Jaramillo A; Smith CR; Maruyama T; Zhang L; Patterson GA; Mohanakumar T
    Hum Immunol; 2003 May; 64(5):521-9. PubMed ID: 12691702
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surrogate markers and risk factors for chronic lung allograft dysfunction.
    Bowdish ME; Arcasoy SM; Wilt JS; Conte JV; Davis RD; Garrity ER; Hertz ML; Orens JB; Rosengard BR; Barr ML
    Am J Transplant; 2004 Jul; 4(7):1171-8. PubMed ID: 15196078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.